Do Intravenous Butaphosphan and Cyanocobalamin Combination Affect Insulin Resistance and Metabolic Profile of Dairy Goats During Their Transition Period?

The lack of substantial differences can be attributed to the limited sample size and the prescribed drug dosage. Further investigations with higher doses exceeding 6 mL are warranted to explore potential effects. Additionally, species-specific differences in ruminants might exist, and caprine metabolism of the compound might differ from that of bovine and ovine. Consequently, we recommend conducting more studies in this field.